OBJECTIVE: Accumulating evidence shows that shared autoimmunity is critical for the pathogenesis of many autoimmune diseases. Systemic sclerosis (SSc) belongs to the connective tissue disorders, and recent data have highlighted strong associations with autoimmunity genes shared with other autoimmune diseases. To determine whether novel risk loci associated with systemic lupus erythematosus or multiple sclerosis may confer susceptibility to SSc, we tested single-nucleotide polymorphisms (SNP) from ITGAM, ITGAX, and CD58 for associations. METHODS: SNP harboring associations with autoimmune diseases, ITGAM rs9937837, ITGAX rs11574637, and CD58 rs12044852, were genotyped in 2 independent cohorts of European Caucasian ancestry: 1031 SSc patients and 1014 controls from France and 1038 SSc patients and 691 controls from the USA, providing a combined study population of 3774 individuals. ITGAM rs1143679 was additionally genotyped in the French cohort. RESULTS: The 4 polymorphisms were in Hardy-Weinberg equilibrium in the 2 control populations, and allelic frequencies were similar to those expected in European Caucasian populations. Allelic and genotypic frequencies for these 3 SNP were found to be statistically similar in SSc patients and controls. Subphenotype analyses for subgroups having diffuse cutaneous subtype disease, specific autoantibodies, or fibrosing alveolitis did not reveal any difference between SSc patients and controls. CONCLUSION: These results obtained through 2 large cohorts of SSc patients of European Caucasian ancestry do not support the implication of ITGAM, ITGAX, and CD58 genes in the genetic susceptibility of SSc, although they were recently identified as autoimmune disease risk genes.
OBJECTIVE: Accumulating evidence shows that shared autoimmunity is critical for the pathogenesis of many autoimmune diseases. Systemic sclerosis (SSc) belongs to the connective tissue disorders, and recent data have highlighted strong associations with autoimmunity genes shared with other autoimmune diseases. To determine whether novel risk loci associated with systemic lupus erythematosus or multiple sclerosis may confer susceptibility to SSc, we tested single-nucleotide polymorphisms (SNP) from ITGAM, ITGAX, and CD58 for associations. METHODS: SNP harboring associations with autoimmune diseases, ITGAMrs9937837, ITGAXrs11574637, and CD58rs12044852, were genotyped in 2 independent cohorts of European Caucasian ancestry: 1031 SSc patients and 1014 controls from France and 1038 SSc patients and 691 controls from the USA, providing a combined study population of 3774 individuals. ITGAM rs1143679 was additionally genotyped in the French cohort. RESULTS: The 4 polymorphisms were in Hardy-Weinberg equilibrium in the 2 control populations, and allelic frequencies were similar to those expected in European Caucasian populations. Allelic and genotypic frequencies for these 3 SNP were found to be statistically similar in SSc patients and controls. Subphenotype analyses for subgroups having diffuse cutaneous subtype disease, specific autoantibodies, or fibrosing alveolitis did not reveal any difference between SSc patients and controls. CONCLUSION: These results obtained through 2 large cohorts of SSc patients of European Caucasian ancestry do not support the implication of ITGAM, ITGAX, and CD58 genes in the genetic susceptibility of SSc, although they were recently identified as autoimmune disease risk genes.
Authors: P Dieudé; M Guedj; J Wipff; B Ruiz; G Riemekasten; M Matucci-Cerinic; I Melchers; E Hachulla; P Airo; E Diot; N Hunzelmann; J Cabane; L Mouthon; J L Cracowski; V Riccieri; J Distler; O Meyer; A Kahan; C Boileau; Y Allanore Journal: Ann Rheum Dis Date: 2010-05-28 Impact factor: 19.103
Authors: E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim Journal: J Rheumatol Date: 1988-02 Impact factor: 4.666
Authors: J S Munger; X Huang; H Kawakatsu; M J Griffiths; S L Dalton; J Wu; J F Pittet; N Kaminski; C Garat; M A Matthay; D B Rifkin; D Sheppard Journal: Cell Date: 1999-02-05 Impact factor: 41.582
Authors: Xana Kim-Howard; Amit K Maiti; Juan-Manuel Anaya; Gail R Bruner; Elizabeth Brown; Joan T Merrill; Jeffrey C Edberg; Michelle A Petri; John D Reveille; Rosalind Ramsey-Goldman; Graciela S Alarcon; Timothy J Vyse; Gary Gilkeson; Robert P Kimberly; Judith A James; Joel M Guthridge; John B Harley; Swapan K Nath Journal: Ann Rheum Dis Date: 2009-11-25 Impact factor: 19.103
Authors: Kelly S Schweitzer; Natini Jinawath; Raluca Yonescu; Kevin Ni; Natalia Rush; Varodom Charoensawan; Irina Bronova; Evgeny Berdyshev; Sonia M Leach; Lucas A Gillenwater; Russel P Bowler; David B Pearse; Constance A Griffin; Irina Petrache Journal: JCI Insight Date: 2020-07-23
Authors: Juan-Manuel Anaya; Xana Kim-Howard; Sampath Prahalad; Alejandra Cherñavsky; Carlos Cañas; Adriana Rojas-Villarraga; John Bohnsack; Roland Jonsson; Anne Isine Bolstad; Johan G Brun; Beth Cobb; Kathy L Moser; Judith A James; John B Harley; Swapan K Nath Journal: Autoimmun Rev Date: 2011-08-05 Impact factor: 9.754
Authors: S Melkorka Maggadottir; Jin Li; Joseph T Glessner; Yun Rose Li; Zhi Wei; Xiao Chang; Frank D Mentch; Kelly A Thomas; Cecilia E Kim; Yan Zhao; Cuiping Hou; Fengxiang Wang; Silje F Jørgensen; Elena E Perez; Kathleen E Sullivan; Jordan S Orange; Tom H Karlsen; Helen Chapel; Charlotte Cunningham-Rundles; Hakon Hakonarson Journal: J Allergy Clin Immunol Date: 2015-02-10 Impact factor: 10.793
Authors: Liliane Fossati-Jimack; Guang Sheng Ling; Andrea Cortini; Marta Szajna; Talat H Malik; Jacqueline U McDonald; Matthew C Pickering; H Terence Cook; Philip R Taylor; Marina Botto Journal: PLoS One Date: 2013-02-22 Impact factor: 3.240